Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.64 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.64 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.64 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.55 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.52 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.52 |
| ▸ | ADH5 | P11766 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8339879 | 0.98 | LMNA (0.96) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL28046795 | 0.98 | LMNA (0.96) | LMNAMAPTENPP2MKNK1MKNK2 | |
| Hydrochloric Acid SCHEMBL3565712 | 0.98 | LMNA (0.96) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL28046704 | 0.98 | LMNA (0.96) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL28046707 | 0.98 | LMNA (0.96) | LMNAMAPTENPP2MKNK1MKNK2 | |
| Hydrochloric Acid SCHEMBL28420692 | 0.98 | LMNA (0.96) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL5836930 | 0.89 | MAPT (0.79) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL10126954 | 0.89 | LMNA (0.79) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL2532397 | 0.89 | LMNA (0.78) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL6324509 | 0.86 | MAPT (0.74) | LMNAMAPTENPP2MKNK1MKNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 766 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354045-A1 | COOLING LIQUID AND COOLING SYSTEM | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2025-11-20 | — | — | US | claimed |
| WO-2025075506-A1 | COATED POROUS MEDIA, METHOD OF MANUFACTURING A COATED POROUS MEDIA AND THE USE OF SUCH COATED POROUS MEDIA | TECHNISCHE UNIVERSITEIT EINDHOVEN (NL) | 2025-04-10 | — | — | WO | claimed |
| CN-118465091-A | Method for enriching and detecting bisphenol based on ionic metal organic framework material | 山东省分析测试中心 | 2024-08-09 | — | — | CN | claimed |
| CN-118272958-A | Preparation method and application of high-strength cellulose-based composite fiber | 界首市盛泰服装科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118120908-A | Method for separating and purifying melanoidin based on pH sensitive metal chelate precipitant, melanoidin and application thereof | 天津现代创新中药科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-114349707-B | N-substituted urea compound and preparation method and application thereof | 中国医学科学院医药生物技术研究所 | 2024-01-09 | — | — | CN | claimed |
| CN-117258568-A | Ionic super-crosslinked polymer film, preparation method and application thereof | 南通斐腾新材料科技有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-111841611-B | Noble metal monatomic catalyst and preparation method assisted by using notch polyacid | 西北工业大学 | 2023-03-14 | — | — | CN | claimed |
| CN-111961091-B | Imidazole derivative polybasic aromatic carboxylate iron complex and preparation method and application thereof | 生态环境部南京环境科学研究所 | 2023-01-31 | — | — | CN | claimed |
| CN-114890991-A | Preparation method and application of hyperbranched bifunctional polymerization ionic liquid catalyst | 东南大学 | 2022-08-12 | — | — | CN | claimed |
| WO-2007121852-A2 | LIGHTENING AND/OR COLOURING AGENTS COMPRISING AMIDINES | HENKEL AG & CO. KGAA (DE) | 2007-11-01 | — | — | WO | claimed |
| WO-2007121853-A2 | LIGHTENING AND/OR COLOURING AGENTS COMPRISING N,N'-OXALYLDIAZOLES AND/OR OXIMIDYLDIAZOLES | HENKEL AG & CO. KGAA (DE) | 2007-11-01 | — | — | WO | claimed |
| WO-2007121851-A1 | LIGHTENING AND/OR COLOURING AGENTS COMPRISING HALOGENATED KETONES | HENKEL AG & CO. KGAA (DE) | 2007-11-01 | — | — | WO | claimed |
| WO-2007118616-A1 | BLEACHING AND/OR COLOURING AGENT WITH IMPROVED SKIN COMPATIBILITY | HENKEL AG & CO. KGAA (DE) | 2007-10-25 | — | — | WO | claimed |
| WO-2007096027-A1 | BLEACHING AGENTS | HENKEL AG & CO. KGAA (DE) | 2007-08-30 | — | — | WO | claimed |
| EP-1773768-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | Exelixis, Inc. (US) | 2007-04-18 | — | — | EP | claimed |
| WO-2006012642-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS, INC. (US) | 2006-02-02 | — | — | WO | claimed |
| US-20050182050-A1 | Therapeutic heterocyclic compounds | ASTRAZENECA AB (SE) | 2005-08-18 | — | — | US | claimed |
| US-6812225-B2 | PYSCHOLOGICAL DISORDERS; ANTIDEPRESSANTS | ASTRAZENECA AB (SE) | 2004-11-02 | — | — | US | claimed |
| US-20030013708-A1 | Therapeutic heterocyclic compounds | ASTRAZENECA AB (SE) | 2003-01-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182050-A1 | Therapeutic heterocyclic compounds | HTR1B, HTR1D, HTR1A | LMNA 1663/4885MAPT 653/4885ENPP2 668/4885 |
| US-20030013708-A1 | Therapeutic heterocyclic compounds | HTR1A, HTR1D, HTR1B | LMNA 1808/4885MAPT 661/4885ENPP2 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.